Related Experiment Video
Updated: Aug 11, 2026

08:06
Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats
Published on: June 18, 2018
The use of the triangular test with response-adaptive treatment allocation
D Stephen Coad1, Anastasia Ivanova
1Department of Mathematics, University of Sussex, Falmer, Brighton BN1 9RF, UK. d.s.coad@sussex.ac.uk
Statistics in Medicine
|February 12, 2005
Summary
The drop-the-loser rule enhances clinical trials by reducing treatment failures and variability when used with the triangular test. This adaptive design improves trial efficiency and patient outcomes compared to equal allocation.
Area of Science:
- Clinical Trials
- Biostatistics
- Medical Research
Background:
- Sequential clinical trials often employ stopping rules like the triangular test to compare treatments.
- Response-adaptive randomization aims to allocate more patients to the better-performing treatment during a trial.
Purpose of the Study:
- To evaluate the impact of adaptive treatment allocation rules on the performance of the triangular test.
- To compare the drop-the-loser rule with other adaptive designs in conjunction with the triangular test.
Main Methods:
- The study analyzes the triangular test combined with various response-adaptive allocation rules, including the drop-the-loser rule.
- Simulation methods are used to assess the performance metrics such as allocation proportion variability and treatment failures.
- Asymptotic properties of the adaptive rules are summarized.
Main Results:
- The drop-the-loser rule demonstrated a less variable allocation proportion and fewer treatment failures compared to other adaptive rules.
- Combining the triangular test with the drop-the-loser rule resulted in fewer average treatment failures than equal allocation.
- The adaptive approach provided comparable statistical power and similar expected sample sizes.
Conclusions:
- The drop-the-loser rule is a promising adaptive design for use with the triangular test in clinical trials.
- This combination offers benefits over equal allocation by reducing treatment failures while maintaining trial efficiency.
- An AIDS clinical trial example illustrates the practical application and benefits of this approach.
Related Concept Videos
Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
McNemar's Test
McNemar's Test is a nonparametric statistical test used to determine if there is a significant difference in proportions between two related groups when the outcome is binary (e.g., yes/no, success/failure). It is beneficial when we have paired data, such as pre-test/post-test designs, where the same subjects are measured under two different conditions. The test is named after the statistician Quinn McNemar, who introduced it in 1947. It is commonly used in situations where subjects are...

